Clinical Perspectives of Gene-Targeted Therapies for Epidermolysis Bullosa

New insights into molecular genetics and pathomechanisms in epidermolysis bullosa (EB), methodological and technological advances in molecular biology as well as designated funding initiatives and facilitated approval procedures for orphan drugs have boosted translational research perspectives for t...

Descripción completa

Detalles Bibliográficos
Autores principales: Welponer, Tobias, Prodinger, Christine, Pinon-Hofbauer, Josefina, Hintersteininger, Arno, Breitenbach-Koller, Hannelore, Bauer, Johann W., Laimer, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322229/
https://www.ncbi.nlm.nih.gov/pubmed/34110606
http://dx.doi.org/10.1007/s13555-021-00561-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322229/
https://www.ncbi.nlm.nih.gov/pubmed/34110606
http://dx.doi.org/10.1007/s13555-021-00561-5

Ejemplares similares